Abstract

P.048 Results of the predict randomised controlled trial: clinical effects of using the predict test to guide antidepressant treatment in depression

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study
Yan Luo ... Georgia Salanti
BMJ open | VOL. 8
Yan Luo, et. al.Yan Luo ... Georgia Salanti
01 Dec 2018
Which patients benefit from adding short-term psychodynamic psychotherapy to antidepressants in the treatment of depression? A systematic review and meta-analysis of individual participant data.
Ellen Driessen ... Veronica G Vitriol
Psychological medicine | VOL. 53
Ellen Driessen, et. al.Ellen Driessen ... Veronica G Vitriol
21 Nov 2022
Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression
Paul A Keedwell ... Mary Phillips
Journal of Affective Disorders | VOL. 120
Paul A Keedwell, et. al.Paul A Keedwell ... Mary Phillips
18 Jun 2009
Antidepressant treatment for depression: total charges and therapy durationSource of funding: Research funded by Eli Lilly and Company. Drs. Croghan, Melfi, and Obenchain are employees and stockholders of Eli Lilly and Company. The study was performed while Dr. Kniesner was a Visiting Research Fellow at Eli Lilly and Company. It was also performed in partial fulfillment of the requirements for
Deborah G Dobrez ... Catherine A Melfi
The Journal of Mental Health Policy and Economics | VOL. 3
Deborah G Dobrez, et. al.Deborah G Dobrez ... Catherine A Melfi
01 Dec 2000
View more papers

More From: European Neuropsychopharmacology

Paper Title
Journal
Date
Author
Ensuring safety in cannabinoid prescriptions: A call for critical assessment
Laura Bueno ... Hugo López-Pelayo
European Neuropsychopharmacology | VOL. 87
Laura Bueno, et. al.Laura Bueno ... Hugo López-Pelayo
20 Jul 2024
Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition
Sydney H James ... Gregory P Strauss
European Neuropsychopharmacology | VOL. 87
Sydney H James, et. al.Sydney H James ... Gregory P Strauss
17 Jul 2024
Ketamine and new targets for treatment-resistant depression: A role for transforming growth factor-β1?
Filippo Caraci ... Filippo Drago
European Neuropsychopharmacology | VOL. 86
Filippo Caraci, et. al.Filippo Caraci ... Filippo Drago
16 Jul 2024
Deciphering the impact of metabolic anomalies in relation to severe mental illness
Clemente Garcia-Rizo ... Byron K.Y Bitanihirwe
European Neuropsychopharmacology | VOL. 87
Clemente Garcia-Rizo, et. al.Clemente Garcia-Rizo ... Byron K.Y Bitanihirwe
16 Jul 2024
View more papers